Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

TILT Holdings Reports First Quarter 2025 Financial Results

LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...

High-Paying Roles in the Cannabis Industry

LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...

  • Fast Buds - German cannabis legalisation

German Medical Cannabis Market Sees Significant Growth

LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...

Beer Gets Burned, Hemp Drinks Heat Up

 New insights from Whitney Economics show hemp beverages could win big as tariffs slam the beer industry The team at Whitney Economics just dropped their latest cannabis and hemp market forecast—and it’s a must-read for ...

Maryland Awards Social Equity Cannabis Licenses

LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...

Organigram Announces Investment in Open Book Extracts

NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD

LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...

Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...

Subscribe To Our Newsletter

Go to Top